• Fluorescein Tyramide in Translational Neuroscience

  2026-09-07

  This thought-leadership article connects recent evidence on early life adversity, oxytocin signaling, and superior colliculus circuitry with practical assay strategy. It explains how Fluorescein Tyramide can support sensitive IHC, ISH, and flow cytometry workflows while distinguishing literature findings from proposed validation steps.

• NMDA for Excitotoxicity Assay Design

  2026-09-05

  NMDA (N-Methyl-D-aspartic acid) provides a direct, controllable trigger for receptor-mediated calcium loading and excitotoxic injury. This practical workflow connects concentration scouting with ferroptosis-aware readouts for retinal ganglion cell and neurodegenerative disease models.

• Aneugen Mechanisms Revealed by Flow Cytometry

  2026-09-04

  Bernacki and colleagues developed a tiered assay that combines DNA-damage biomarkers, Taxol-associated fluorescence, phospho-histone H3, Ki-67, clustering, and machine learning to distinguish major aneugenic mechanisms. The workflow provides a mechanistic complement to micronucleus testing by separating tubulin stabilization, tubulin destabilization, and mitotic kinase inhibition in TK6 cells.

• Amikacin disulfate: Mechanism Study Workflows

  2026-09-04

  Amikacin disulfate supports more than routine antibacterial screening: it can connect 16S rRNA-centered mechanism studies with orthogonal protein-binding and activity assays. This workflow-driven guide shows how to prepare the compound, validate assay signals, investigate lysozyme complexation, and troubleshoot instability or misleading readouts.

• Annexin V-Cy5: Separating Apoptosis from Lysosomal Stress

  2026-09-03

  In zebrafish microglia, mestranol can impair lysosomal digestion without increasing neuronal apoptosis. This thought-leadership guide explains how Annexin V-Cy5 apoptosis detection can serve as a mechanistic checkpoint, helping translational researchers distinguish phosphatidylserine exposure and true cell death from cargo accumulation, altered lysosomal function, and imaging artifacts.

• Nicotinamide Riboside Chloride in RGC Research

  2026-09-03

  Nicotinamide Riboside Chloride (NIAGEN) provides a practical way to test NAD+ metabolism in chemically defined retinal ganglion cell models. This article connects the compound’s metabolic applications with an efficient iPSC-to-RGC workflow while separating established evidence from proposed experimental extensions.

• Targeted Amikacin Delivery into Mycobacterial Granulomas

  2026-09-02

  The reference study developed a cell-based strategy to transport fluorescently labeled amikacin into Mycobacterium avium granulomas in infected mice. Its central contribution is a proof of targeted delivery using primed dendritic cells, while preserving measurable antimycobacterial activity and avoiding detectable increases in selected inflammatory markers.

• Cy3 Goat Anti-Human IgG (H+L) Antibody Workflow

  2026-09-02

  Build sensitive human IgG detection workflows for immunofluorescence, tissue imaging, flow cytometry, and ELISA with a Cy3-conjugated secondary antibody. Practical controls, optimization ranges, and troubleshooting guidance help connect antibody-binding assays with translational orthopoxvirus research without confusing detection with neutralization.

• Cy3 Goat Anti-Human IgG (H+L) Antibody Workflow

  2026-09-01

  Build sensitive human-IgG detection workflows for immunofluorescence, tissue imaging, flow cytometry, and fluorescent ELISA with a Cy3 conjugated secondary antibody. This guide also explains how to translate antibody-characterization insights from orthopoxvirus research into better assay controls without confusing a detection reagent with an antiviral therapeutic.

• Inflammation in Ischemic Stroke: Biomarkers to Treatment

  2026-09-01

  The 2025 Frontiers in Immunology review by Xiao et al. integrates inflammatory mechanisms, biomarker applications, and treatment research in ischemic stroke. Its main value is a time- and compartment-aware framework that connects blood–brain barrier disruption, central and peripheral immunity, diagnostic interpretation, and therapeutic development while emphasizing the limits of current evidence.

• Hydrazide VEGFR-2 Inhibitors: SA7 and Antiangiogenesis

  2026-08-31

  A ChemistrySelect study designed and evaluated 53 hydrazide-based derivatives as VEGFR-2-directed anticancer candidates. SA7 showed low-micromolar cytotoxicity, VEGFR-2 inhibition comparable to Sorafenib, suppression of endothelial tube formation, and stronger HCT116 xenograft control than irinotecan, supporting hydrazide scaffolds as useful starting points for antiangiogenic drug discovery.

• Salvianolic acid B: Reliable Assay Workflows

  2026-08-31

  This scenario-driven guide shows how Salvianolic acid B (SKU N1806) can support reproducible viability, proliferation, and pulmonary fibrosis research assays. It connects LH2-associated collagen remodeling evidence with practical guidance on controls, solubility, interpretation, and research-grade product selection.

• Annexin V-Cy5 Apoptosis in Lysosomal Stress

  2026-08-30

  A mechanistic and translational guide to using Annexin V-Cy5 apoptosis detection to distinguish phosphatidylserine exposure from lysosomal dysfunction in microglia, with practical recommendations for zebrafish, flow cytometry, and fluorescence microscopy workflows.

• Cy3 Goat Anti-Human IgG (H+L) Antibody

  2026-08-29

  A scenario-based laboratory guide to using Cy3 Goat Anti-Human IgG (H+L) Antibody, SKU K1208, in immunofluorescence, flow cytometry, immunohistochemistry, and ELISA workflows. It explains compatibility, controls, storage, signal interpretation, and vendor-selection criteria without treating fluorescence as a direct substitute for viability measurements.

• L-Ornithine and the Liver–Brain Axis

  2026-08-28

  L-Ornithine is more than a urea cycle intermediate: it is a controllable metabolic probe for testing how hepatic nitrogen handling may influence astrocyte energy metabolism. This thought-leadership article translates recent realgar-toxicity findings into a practical framework for liver–brain axis research, covering mechanistic rationale, assay design, reagent selection, translational boundaries, and the next experiments needed to distinguish correlation from causality.

8116 records 1/542 page Next 12345 下5页 Last page